CAPTRUST Financial Advisors
IDYA icon

CAPTRUST Financial Advisors’s IDEAYA Biosciences IDYA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-738
Closed -$10K – 2996
2022
Q2 		$10K Hold
738
– – ﹤0.01% 3746
2022
Q1 		$8K Sell
738
-61
-8% -$899 ﹤0.01% 3914
2021
Q4 		$19K Buy
799
+61
+8% +$1.42K ﹤0.01% 3312
2021
Q3 		$19K Buy
+738
New +$17.2K ﹤0.01% 3199

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAPTRUST Financial Advisors's IDYA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of IDEAYA Biosciences (IDYA) in Q3 2022, closing a stake of 738 shares — an estimated $10K sold.

CAPTRUST Financial Advisors first reported a position in IDYA in Q3 2021 and held it in 4 quarters. The position peaked at $19K in Q4 2021. 112 funds tracked by Wall St. Rank hold IDYA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining IDEAYA Biosciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 738 IDEAYA Biosciences shares in Q3 2022, an estimated $10K.
  • CAPTRUST Financial Advisors first reported a position in IDEAYA Biosciences in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's IDEAYA Biosciences position peaked at $19K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.